CORC  > 吉林大学白求恩第一医院
A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer
Shu, Yongqian; Lu, Zhihao; Zhang, Xiaotian; Liu, Wei; Liu, Tianshu; Hu, Bing; Li, Wei; Fan, Qingxia; Xu, Jianming; Xu, Nong
刊名GASTRIC CANCER
2018
卷号21期号:5
关键词Stomach neoplasms Paclitaxel Capecitabine Cisplatin
ISSN号1436-3291
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3538143
专题吉林大学白求恩第一医院
推荐引用方式
GB/T 7714
Shu, Yongqian,Lu, Zhihao,Zhang, Xiaotian,et al. A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer[J]. GASTRIC CANCER,2018,21(5).
APA Shu, Yongqian.,Lu, Zhihao.,Zhang, Xiaotian.,Liu, Wei.,Liu, Tianshu.,...&Shen, Lin.(2018).A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer.GASTRIC CANCER,21(5).
MLA Shu, Yongqian,et al."A multicenter, randomized trial comparing efficacy and safety of paclitaxel/capecitabine and cisplatin/capecitabine in advanced gastric cancer".GASTRIC CANCER 21.5(2018).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace